Quick Picks - Sarepta Therapeutics (NASDAQ:SRPT) is up nearly 13% in pre-market trading on a story highlighting a Duchenne Muscular Dystrophy (DMD) patient’s progress on the company’s development-stage … Continue Reading
Read nowLong Ideas - The CEO of Spectrum Pharmaceuticals (NASDAQ:SPPI) will present today in Southern California at an investor conference (12:00pm EST, webcast available at www.sppirx.com). In addition to … Continue Reading
Read nowQuick Picks - Warner Chilcott (NASDAQ:WCRX) opened down 23% from Tuesday’s closing price of $16.90 after the company announced that the ex-dividend date for its $4 special dividend … Continue Reading
Read nowLong Ideas - A Bloomberg article today illustrates the Street’s bullish outlook on Achillion Pharmaceuticals (NASDAQ:ACHN) as a takeover candidate. Following the failure of Hep C compounds being developed … Continue Reading
Read nowQuick Picks - ArQule Inc. (NASDAQ:ARQL), co-developer of the tivantinib cancer treatment, received word from its Japanese partner Kyowa Hakko Kirin Co., that Kyowa has suspended patient enrollment … Continue Reading
Read nowLong Ideas - Shares of Halozyme Therapeutics (NASDAQ:HALO) have recovered nicely since the stock was cut in half on news related to the company’s partnered products with Baxter … Continue Reading
Read nowShort Ideas - Discovery Laboratories (NASDAQ:DSCO) has moved up 28% on trading momentum following a Buy rating on the 24th. The company’s lead product, Surfaxin, was approved by … Continue Reading
Read now